Stay updated on MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial page.

Latest updates to the MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedAdded related topics: Ovarian cancer and MedlinePlus Genetics to the study page.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0, indicating a minor update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page removed an ancillary funding notice and related topics links (Ovarian cancer and MedlinePlus Genetics). Core trial information remains unchanged.SummaryDifference0.5%

- Check42 days agoChange DetectedNo significant changes detected between the screenshots. The page remains the Study Details page for MITO27 (NCT03539328) with the same sections and content.SummaryDifference0.4%

- Check56 days agoChange DetectedRemoved the MedlinePlus Genetics topic on ovarian cancer, narrowing the page's coverage of that specific topic.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

Stay in the know with updates to MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo vs Chemotherapy in Ovarian Cancer Clinical Trial page.